Peijia Medical Limited (4WO) - Cash Flow Conversion Efficiency

Latest as of June 2023: -0.096x

Based on the latest financial reports, Peijia Medical Limited (4WO) has a cash flow conversion efficiency ratio of -0.096x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-235.16 Million ≈ $-274.93 Million USD) by net assets (€2.44 Billion ≈ $2.86 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 4WO defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Peijia Medical Limited - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Peijia Medical Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Peijia Medical Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Peijia Medical Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Jiangsu Xinning Modern Logist
SHE:300013
0.206x
Shandong Sito Bio-technology Co Ltd
SHE:300583
0.008x
YUEXIU SERVICES GROUP LTD
F:5R9
N/A
Materialise NV
NASDAQ:MTLS
0.027x
Silence Therapeutics PLC
NASDAQ:SLN
-0.147x
Citizens Financial Services Inc. Common Stock
NASDAQ:CZFS
0.052x
Tehmag Foods
TWO:1264
0.094x
STP&I Public Company Limited
BK:STPI
0.040x

Annual Cash Flow Conversion Efficiency for Peijia Medical Limited (2018–2025)

The table below shows the annual cash flow conversion efficiency of Peijia Medical Limited from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see Peijia Medical Limited (4WO) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €1.86 Billion
≈ $2.17 Billion
€-20.89 Million
≈ $-24.42 Million
-0.011x -343.81%
2024-12-31 €2.04 Billion
≈ $2.39 Billion
€-5.18 Million
≈ $-6.06 Million
-0.003x +99.09%
2023-12-31 €2.27 Billion
≈ $2.66 Billion
€-630.91 Million
≈ $-737.60 Million
-0.277x -94.52%
2022-12-31 €2.64 Billion
≈ $3.08 Billion
€-376.20 Million
≈ $-439.81 Million
-0.143x +1.32%
2021-12-31 €3.02 Billion
≈ $3.53 Billion
€-436.37 Million
≈ $-510.16 Million
-0.145x -124.52%
2020-12-31 €2.81 Billion
≈ $3.29 Billion
€-181.10 Million
≈ $-211.72 Million
-0.064x -135.03%
2019-12-31 €-558.21 Million
≈ $-652.60 Million
€-102.59 Million
≈ $-119.94 Million
0.184x -55.23%
2018-12-31 €-94.34 Million
≈ $-110.29 Million
€-38.73 Million
≈ $-45.28 Million
0.411x --

About Peijia Medical Limited

F:4WO Germany Medical Devices
Market Cap
$319.35 Million
€273.16 Million EUR
Market Cap Rank
#14619 Global
#1453 in Germany
Share Price
€0.41
Change (1 day)
-4.67%
52-Week Range
€0.41 - €1.01
All Time High
€3.90
About

Peijia Medical Limited, together with its subsidiaries, engages in the research, development, manufacturing, and sales of transcatheter valve therapeutic and neurointerventional procedural medical devices in the People's Republic of China. It operates through Transcatheter Valve Therapeutic Business, Neurointerventional Business, and Future Technology Business segments. The company's products inc… Read more